AVITA Medical Inc
RCEL
NASDAQ
Biotechnology
$7.85
USD
-0.16 (-2.00%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $247.72M
Volume 270.6K
Revenue
$75.63M
TTM
+1.0%
YoY
Gross Margin
82%
TTM
-3.2%
YoY
Net Income
$-43.08M
TTM
+16.5%
YoY
Operating Cash Flow
$-24.23M
TTM
+32.4%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 18.4 | 17.1 | 17.6 | 19.3 | 21.7 |
YoY Growth | +21.2% | -12.7% | -4.3% | +4.0% | +17.8% |
Cost of Revenue | 3.5 | 3.2 | 3.3 | 3.5 | 3.9 |
Gross Profit | 14.9 | 13.9 | 14.3 | 15.7 | 17.8 |
Selling, General & Administrative | 21.0 | 19.3 | 19.0 | 18.9 | 19.5 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 26.1 | 23.0 | 24.7 | 24.5 | 24.6 |
Operating Income | -11.1 | -9.2 | -10.4 | -8.8 | -6.9 |
EBITDA | -10.6 | -8.6 | -9.7 | -8.2 | -6.3 |
Other Income / Expense | 2.5 | -2.8 | 0.0 | -0.4 | 0.7 |
Total Other Income / Expense | 1.2 | -4.0 | -1.2 | -1.8 | -0.8 |
Income Before Income Taxes | -9.9 | -13.2 | -11.6 | -10.6 | -7.6 |
Income Taxes | 0.0 | 0.0 | -0.0 | -0.0 | 0.0 |
Net Income | -9.9 | -13.2 | -11.6 | -10.6 | -7.7 |
Consolidated Net Income / Loss | -9.9 | -13.2 | -11.6 | -10.6 | -7.7 |
Net Income Attributable to Common Shareholders | -9.9 | -13.2 | -11.6 | -10.6 | -7.7 |
Basic EPS | -$0.38 | -$0.46 | -$0.38 | -$0.35 | -$0.25 |
Diluted EPS | -$0.38 | -$0.46 | -$0.38 | -$0.35 | -$0.25 |
Basic Shares Outstanding | 26.4M | 28.4M | 30.4M | 30.5M | 30.7M |
Diluted Shares Outstanding | 26.4M | 28.4M | 30.4M | 30.5M | 30.7M |